John Perry is a graduate of the Auckland Medical School and completed specialist training in Gastroenterology and Internal Medicine in Auckland and the UK. He did fellowships in Hepatology at Royal Prince Alfred Hospital in Sydney and in both Hepatology and Inflammatory Bowel Disease at the John Radcliffe Hospital in Oxford, UK. He has continued working in both Luminal GI and Hepatology fields, and is the Hepatology Lead at WDHB.
Fatty Liver – A Relevant Update For The General Physician
Non-alcoholic Fatty Liver Disease (NAFLD) is on the rise, mirroring the global epidemic of obesity. At least 20% of New Zealanders have it, probably more. Patients with bland fatty liver do not usually progress to significant liver disease. However, some patients with NAFLD have Non-alcoholic Steatohepatitis (NASH), and are at risk of progressing to cirrhosis, liver failure, or developing HCC.
So who is at risk, who should you refer, and what can we do about it?